Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
[Acute disseminated encephalomyelitis (ADEM): its diagnostic criteria and therapy].
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Colour vision impairment is associated with disease severity in multiple sclerosis.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 with MOG: Evidence of Involvement of B Cells.
Progression in multiple sclerosis is associated with low endogenous NCAM.
Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Modulating effects of WT1 on interferon-β-vitamin D association in MS.
Paracrine Effects of Mesenchymal Stem Cells-Conditioned Medium on Microglial Cytokines Expression and Nitric Oxide Production.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Pregnancy and multiple sclerosis.
[Ultrahigh field MRI in context of neurological diseases.]
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Vitamin D as a protective factor in multiple sclerosis.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.

Pages